{"componentChunkName":"component---src-templates-chapter-level-1-chapter-level-1-tsx","path":"/topics/post-herpetic-neuralgia/prescribing-information/","result":{"pageContext":{"chapter":{"id":"6932895c-9dfd-5da5-a4dd-cba579bf4edd","slug":"prescribing-information","fullItemName":"Prescribing information","depth":1,"htmlHeader":"<!-- begin field c6023ec6-6fef-4257-a5a2-e476bf75a6b1 --><h1>Prescribing information</h1><!-- end field c6023ec6-6fef-4257-a5a2-e476bf75a6b1 -->","summary":null,"htmlStringContent":"<!-- begin item 938e5965-3f33-4a45-8146-09b3542b70c6 --><!-- begin field b748bd77-e589-4ace-bf9c-a73c013125ed --><p>Important aspects of prescribing information relevant to primary healthcare are covered in this section specifically for the drugs recommended in this CKS topic. For further information on contraindications, cautions, drug interactions, and adverse effects, see the <a href=\"http://www.medicines.org.uk/emc\" data-hyperlink-id=\"c44eb574-f290-4788-8391-a98f01710a86\">electronic Medicines Compendium</a> (eMC), or the <a href=\"https://bnf.nice.org.uk/\" data-hyperlink-id=\"7aa6fd74-8b03-4c6a-a4df-a98f01710b02\">British National Formulary</a> (BNF).</p><!-- end field b748bd77-e589-4ace-bf9c-a73c013125ed --><!-- end item 938e5965-3f33-4a45-8146-09b3542b70c6 -->","topic":{"id":"54614fe0-8a47-5df0-b8e9-67d6417eac0d","topicId":"42508b4e-7987-4ff7-9cd1-647315a678b7","topicName":"Post-herpetic neuralgia","slug":"post-herpetic-neuralgia","lastRevised":"Last revised in July 2017","chapters":[{"id":"b4e97191-f5f0-5efa-bc32-1a8739fb0524","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"a657749a-6629-5da1-bf22-9d164969ca93","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"36c8e1f0-287e-5380-bc4f-f42ddf04e983","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"f8c609d4-05b5-538c-b9c6-d643d7e7f5e8","slug":"changes","fullItemName":"Changes"},{"id":"92f79bd2-9e70-52dd-b404-510400482111","slug":"update","fullItemName":"Update"}]},{"id":"addbece3-3dce-55c5-83b0-bd2fdd225c1f","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"a3192eb2-159a-5ddf-82bf-24a9364207ee","slug":"goals","fullItemName":"Goals"},{"id":"4f386102-bf02-582c-9139-eb6d81f97852","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"9b2dd798-4f3c-5194-a525-6fd005d0e2d3","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"e4d6aaad-13cc-5127-b315-04879ba584e5","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"6384851a-a5ee-56c3-ae26-accd5a02bda2","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"f1189ae3-2db8-502c-aa1f-3de86bbd0aec","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"11d0f24e-273c-5602-a2a2-c1f9b6afb8fd","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"e8bc827a-09c6-5d81-b648-e6aab18f479a","slug":"definition","fullItemName":"Definition"},{"id":"7d11ac85-acf6-5480-a72d-baaa197a6cd0","slug":"prevalence","fullItemName":"Prevalence"},{"id":"bcc711bf-9832-566c-86d0-a73e6f90ec7c","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"59f87b98-5214-5e7d-9f01-6ee75d527557","slug":"prognosis","fullItemName":"Prognosis"},{"id":"bbcea3ba-c2de-5140-8aa3-38794493bac7","slug":"complications","fullItemName":"Complications"}]},{"id":"d9de53aa-a485-59fd-890b-c2e883790326","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"4106210e-2a16-5414-a10f-2e6f04295872","slug":"diagnosis","fullItemName":"Diagnosis"}]},{"id":"f6decb43-bacd-5d0d-bf99-39695913260e","fullItemName":"Management","slug":"management","subChapters":[{"id":"8de90f5c-0670-56d7-b5c7-dd38335fe889","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"6932895c-9dfd-5da5-a4dd-cba579bf4edd","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"75ab84b5-9461-5828-a2ca-b50bf9f35cc0","slug":"neuropathic-pain-treatments","fullItemName":"Neuropathic pain treatments"},{"id":"e7ce9ec1-b3a2-5b78-a4e1-2e41055c4dcd","slug":"paracetamol-codeine","fullItemName":"Paracetamol and codeine"},{"id":"3b69fe1d-39be-5060-a4c5-001c53ce1c70","slug":"lidocaine-plasters","fullItemName":"Lidocaine plasters"}]},{"id":"53bc33fd-0728-532f-a15f-1caa6952c0f9","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"8aa7ebb2-f0d7-5611-9ea0-3ed478028b44","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"7e4288c2-3520-5856-bcd6-efe055368823","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"c99e378c-55fa-5f4e-9bc3-33949142e857","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"f1d65c20-04ce-5fa3-a7a4-dfc340714178","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"fd48516c-88c8-51e3-b7f9-231b96ff1bce","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"28d25826-2b2a-5f6f-822b-598bd4997c64","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"0aa7c920-194e-5c04-ae6a-32f5ef3734ec","fullItemName":"References","slug":"references","subChapters":[]}]},"subChapters":[{"id":"75ab84b5-9461-5828-a2ca-b50bf9f35cc0","slug":"neuropathic-pain-treatments","fullItemName":"Neuropathic pain treatments","summary":""},{"id":"e7ce9ec1-b3a2-5b78-a4e1-2e41055c4dcd","slug":"paracetamol-codeine","fullItemName":"Paracetamol and codeine","summary":""},{"id":"3b69fe1d-39be-5060-a4c5-001c53ce1c70","slug":"lidocaine-plasters","fullItemName":"Lidocaine plasters","summary":""}]}}},"staticQueryHashes":["3666801979"]}